With a bit of funding, high school students not only helped their neighbors but also offered researchers insights into how young people think about their capacity to make a difference.
Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.
The Northeast Regional Center for Excellence in Vector-Borne Diseases, led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention to train and educate vector-borne disease professionals.
An interdisciplinary research team received a five-year, $2 million grant from the National Science Foundation to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
Cornell researchers attached large fragments to temperamental "radical" molecules, increasing their girth to insulate them from their hyperreactive partners – a method that could help create improved derivatives of pharmaceutical compounds.
When wildfires draped smoke over New York this summer, nearly half of its counties lacked data on air quality. Cornell has led an effort to install sensors in places where there were none.
A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine.
Eight projects have been selected from the Fall 2023 application cycle to receive Ignite Innovation Acceleration grants. The grants are designed to help project teams pursue licensing, form startups, and forge industry collaborations.